                         SEQUENCE LISTING

<110>  Inserm
 
<120>  PEPTIDES AND USES THEREOF FOR REDUCING CD95-MEDIATED CELL 
       MOTILITY

<130>  BIO15313 LEGEMBRE / MC

<160>  7     

<170>  PatentIn version 3.5

<210>  1
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  peptide of the invention


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  X represents A, T, C, or K

<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  X represents A or C

<220>
<221>  MISC_FEATURE
<222>  (5)..(5)
<223>  X represents A, H, N, or R

<220>
<221>  MISC_FEATURE
<222>  (6)..(6)
<223>  X represents A, K, or L

<400>  1

Xaa Xaa Arg Lys Xaa Xaa Lys 
1               5           


<210>  2
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  peptide of the present invention


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  X represents A, T, C, or K

<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  X represents A or C

<220>
<221>  MISC_FEATURE
<222>  (5)..(5)
<223>  X represents A, H, N, or R

<220>
<221>  MISC_FEATURE
<222>  (6)..(6)
<223>  X represents A, K, or L

<400>  2

Xaa Xaa Arg Lys Xaa Xaa Lys Glu 
1               5               


<210>  3
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  peptide of the present invention

<400>  3

Thr Cys Arg Lys His Arg Lys 
1               5           


<210>  4
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  peptide of the present invention

<400>  4

Thr Cys Arg Lys His Arg Lys Glu 
1               5               


<210>  5
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  control

<400>  5

Thr Cys Ala Ala His Arg Ala 
1               5           


<210>  6
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  control

<400>  6

Thr Cys Ala Ala His Arg Lys 
1               5           


<210>  7
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  SEQ ID NO:7

<400>  7

Pro Pro Val Pro Pro Gln Arg 
1               5           


